According to the knowledge base, Tyvaso (Treprostinil) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease. It is taken four times a day by inhalation Show Full Answer

According to the knowledge base, Tyvaso (Treprostinil) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease. It is taken four times a day by inhalation using a specialized Tyvaso inhalation system.

One member of myPHteam mentioned, “I take Tyvaso and it has helped!”

For more detailed information, you can visit the Tyvaso website: [Tyvaso — United Therapeutics](https://www.tyvaso.com/dtc).

 This AI-generated response comes from myPHteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Tyvaso (Treprostinil) for Pulmonary Hypertension | myPHteam

New Pulmonary Arterial Hypertension Medications: 4 Advances in Treatment | myPHteam